Merck Bullish On Vioxx Deal As Deadline Passes

Law360, New York (January 16, 2008, 12:00 AM EST) -- Now that the first significant deadline in the Vioxx settlement agreement has passed, Merck & Co. says it is confident the plaintiffs will be able to meet the requirements for the $4.85 billion deal to be completed.

Midnight Tuesday was the deadline for all the plaintiffs to register claims alleging the withdrawn painkiller caused them to suffer a heart attack or stroke.

Kent Jarrell, a spokesman for the Vioxx litigation team, said Wednesday that “55,000 and counting” claims were filed before the deadline.

Russ Herman, plaintiffs'...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.